Toth Financial Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Toth Financial Advisory’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.7K	Buy	22 +2	+10%	+$1.51K	﹤0.01%	528
2026 Q2	$12.5K	Buy	20 +19	+1,900%	+$12.9K	﹤0.01%	561
2026 Q1	$773	Buy	+1	New	+$766	﹤0.01%	831
2023 Q2	–	Sell	-8	Closed	-$6.57K	–	874
2023 Q1	$6.57K	Buy	+8	New	+$6.03K	﹤0.01%	507
2022 Q3	–	Sell	-9	Closed	-$5K	–	785
2022 Q2	$5K	Buy	9 +4	+80%	+$2.6K	﹤0.01%	519
2022 Q1	$3K	Hold	5	–	–	﹤0.01%	596
2021 Q4	$3K	Hold	5	–	–	﹤0.01%	618
2021 Q3	$3K	Hold	5	–	–	﹤0.01%	617
2021 Q2	$3K	Hold	5	–	–	﹤0.01%	562
2021 Q1	$2K	Hold	5	–	–	﹤0.01%	606
2020 Q4	$2K	Hold	5	–	–	﹤0.01%	545
2020 Q3	$3K	Hold	5	–	–	﹤0.01%	459
2020 Q2	$3K	Hold	5	–	–	﹤0.01%	448
2020 Q1	$2K	Hold	5	–	–	﹤0.01%	394
2019 Q4	$2K	Buy	+5	New	+$1.68K	﹤0.01%	431

Other funds holding REGN

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

SBWIC

Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return

NPPM

North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return

Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return

Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Toth Financial Advisory's REGN Position: Q3 2026 in Review

Toth Financial Advisory increased its Regeneron Pharmaceuticals (REGN) stake by 10% in Q3 2026, buying an estimated $1.51K and bringing the position to 22 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #528.

Toth Financial Advisory first reported a position in REGN in Q4 2019 and has held it in 15 quarters since. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

Toth Financial Advisory held 22 shares of Regeneron Pharmaceuticals worth $16.7K as of Q3 2026.
Toth Financial Advisory bought 2 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $1.51K.
Regeneron Pharmaceuticals made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #528 holding.
Toth Financial Advisory first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 15 quarters since.
54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.